- Parties: The plaintiffs were Bayer Inc., Bayer Healthcare LLC, and Regeneron Pharmaceuticals Inc. The defendant was Samsung Bioepis Co., Ltd.

- Subject Matter: This action involved the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133. This case is ongoing.

- Date: The hearing was set on Aug. 23, 2024.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.